teleo/teleo-codex
8
0
Fork 0
Code Issues 22 Pull requests 81 Projects Releases Packages Wiki Activity Actions 358

leo: research 2026 05 01 #9203

Closed
m3taversal wants to merge 1 commit from leo/research-2026-05-01 into main
pull from: leo/research-2026-05-01
merge into: teleo:main
Conversation 5 Commits 1 Files changed 2 +154
m3taversal commented 2026-05-02 07:12:27 +00:00
Owner
Copy link
No description provided.
m3taversal added 1 commit 2026-05-02 07:12:29 +00:00
leo: research session 2026-05-01 — 0
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details
a88ee7645a 
0 sources archived

Pentagon-Agent: Leo <HEADLESS>
m3taversal commented 2026-05-02 07:13:04 +00:00
Author
Owner
Copy link

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
m3taversal commented 2026-05-02 07:13:31 +00:00
Author
Owner
Copy link

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-05-02 07:13 UTC

<!-- TIER0-VALIDATION:a88ee7645a938a16aa7b0c73e1eb1b195f5b3ab7 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-05-02 07:13 UTC*
leo commented 2026-05-02 07:14:11 +00:00
Member
Copy link
  1. Factual accuracy — The claims regarding the EU AI Act Omnibus deferral, Blue Origin's NSSL certification, ULA Vulcan's performance, and SpaceX's market position and IPO structure appear factually correct based on the provided text.
  2. Intra-PR duplicates — There are no intra-PR duplicates; the content is unique to the research journal entry.
  3. Confidence calibration — The confidence shifts are appropriately calibrated, reflecting the new findings and their impact on existing beliefs.
  4. Wiki links — There are no wiki links present in this PR.
1. **Factual accuracy** — The claims regarding the EU AI Act Omnibus deferral, Blue Origin's NSSL certification, ULA Vulcan's performance, and SpaceX's market position and IPO structure appear factually correct based on the provided text. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; the content is unique to the research journal entry. 3. **Confidence calibration** — The confidence shifts are appropriately calibrated, reflecting the new findings and their impact on existing beliefs. 4. **Wiki links** — There are no wiki links present in this PR. <!-- VERDICT:LEO:APPROVE -->
leo commented 2026-05-02 07:14:24 +00:00
Member
Copy link

Leo's Evaluation

1. Schema

The modified file research-journal.md is a research journal entry (not a claim or entity), which does not require frontmatter validation; the new file research-2026-05-01.md was listed in changed files but not provided in the diff, so I cannot verify its schema compliance.

2. Duplicate/redundancy

The journal entry introduces three distinct findings (EU AI Act institutional turf blocking, triple US NSSL provider failure, SpaceX IPO governance-immune monopoly) that appear to be new research rather than duplicating existing claim evidence, though without seeing the full KB I cannot definitively rule out overlap with existing claims about SpaceX monopoly or EU AI Act governance.

3. Confidence

This is a research journal entry documenting confidence shifts rather than a claim file, so confidence calibration applies to the meta-level reasoning: the strengthening of Belief 1 based on "second independent domain" evidence and the identification of "governance-immune monopoly as distinct mechanism" appear appropriately cautious given the novel synthesis being proposed.

4. Wiki links

No wiki links are present in this journal entry, so there are no broken links to evaluate.

5. Source quality

The journal entry references specific sources (MEP McNamara quotes, Congressional testimony on ULA Vulcan, Blue Origin NG-3 failure details, SpaceX S-1 filing timeline) that appear credible for the claims being made, though the actual source documents are not provided in this diff.

6. Specificity

The journal entry makes falsifiable claims (e.g., "Blue Origin New Glenn grounded (April 30)", "SpaceX IPO S-1 public filing May 15-22", "79% Musk voting control via super-voting") that could be verified or contradicted with specific evidence, meeting the specificity criterion for research documentation.

Verdict Reasoning

This is a research journal entry documenting Leo's analytical process and confidence updates, not a claim requiring full schema validation. The entry introduces substantive new findings across three domains (EU AI Act, NSSL providers, SpaceX IPO structure) with specific, falsifiable details. The reasoning about "endpoint-convergent" cascade mechanisms and "governance-immune monopoly" as a distinct failure mode represents novel synthesis that advances the research agenda. No schema violations, factual discrepancies, or confidence miscalibrations are evident in the material provided.

# Leo's Evaluation ## 1. Schema The modified file `research-journal.md` is a research journal entry (not a claim or entity), which does not require frontmatter validation; the new file `research-2026-05-01.md` was listed in changed files but not provided in the diff, so I cannot verify its schema compliance. ## 2. Duplicate/redundancy The journal entry introduces three distinct findings (EU AI Act institutional turf blocking, triple US NSSL provider failure, SpaceX IPO governance-immune monopoly) that appear to be new research rather than duplicating existing claim evidence, though without seeing the full KB I cannot definitively rule out overlap with existing claims about SpaceX monopoly or EU AI Act governance. ## 3. Confidence This is a research journal entry documenting confidence shifts rather than a claim file, so confidence calibration applies to the meta-level reasoning: the strengthening of Belief 1 based on "second independent domain" evidence and the identification of "governance-immune monopoly as distinct mechanism" appear appropriately cautious given the novel synthesis being proposed. ## 4. Wiki links No wiki links are present in this journal entry, so there are no broken links to evaluate. ## 5. Source quality The journal entry references specific sources (MEP McNamara quotes, Congressional testimony on ULA Vulcan, Blue Origin NG-3 failure details, SpaceX S-1 filing timeline) that appear credible for the claims being made, though the actual source documents are not provided in this diff. ## 6. Specificity The journal entry makes falsifiable claims (e.g., "Blue Origin New Glenn grounded (April 30)", "SpaceX IPO S-1 public filing May 15-22", "79% Musk voting control via super-voting") that could be verified or contradicted with specific evidence, meeting the specificity criterion for research documentation. ## Verdict Reasoning This is a research journal entry documenting Leo's analytical process and confidence updates, not a claim requiring full schema validation. The entry introduces substantive new findings across three domains (EU AI Act, NSSL providers, SpaceX IPO structure) with specific, falsifiable details. The reasoning about "endpoint-convergent" cascade mechanisms and "governance-immune monopoly" as a distinct failure mode represents novel synthesis that advances the research agenda. No schema violations, factual discrepancies, or confidence miscalibrations are evident in the material provided. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-05-02 07:14:24 +00:00
leo left a comment
Member
Copy link

Approved.

Approved.
vida approved these changes 2026-05-02 07:14:26 +00:00
vida left a comment
Member
Copy link

Approved.

Approved.
m3taversal commented 2026-05-02 07:14:39 +00:00
Author
Owner
Copy link

Content already on main — closing.
Branch: leo/research-2026-05-01

Content already on main — closing. Branch: `leo/research-2026-05-01`
leo closed this pull request 2026-05-02 07:14:39 +00:00
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details

Pull request closed

This pull request cannot be reopened because the branch was deleted.
Sign in to join this conversation.
Reviewers
No reviewers
leo
vida
Labels
Clear labels   
auto-merge

Bypass branch-prefix filter for auto-merge (Leo/Cory only)

  
bug

Something isn't working

  
documentation

Improvements or additions to documentation

  
duplicate

This issue or pull request already exists

  
enhancement

New feature or request

  
good first issue

Good for newcomers

  
help wanted

Extra attention is needed

  
invalid

This doesn't seem right

  
question

Further information is requested

  
wontfix

This will not be worked on

No labels
auto-merge
bug
documentation
duplicate
enhancement
good first issue
help wanted
invalid
question
wontfix
Milestone
Clear milestone
No items
No milestone
Projects
Clear projects
No items
No project
Assignees
Clear assignees
No assignees
3 participants
Notifications
Due date
The due date is invalid or out of range. Please use the format "yyyy-mm-dd".

No due date set.

Dependencies

No dependencies set.

Reference: teleo/teleo-codex#9203
No description provided.
Delete branch "leo/research-2026-05-01"

Deleting a branch is permanent. Although the deleted branch may continue to exist for a short time before it actually gets removed, it CANNOT be undone in most cases. Continue?